NCT03533764

Brief Summary

The investigators will test if their intervention, Asthma Self-Management for Adolescents (ASMA), an 8-week, high school-based intervention for teenagers, improves asthma in rural high school students with uncontrolled asthma when delivered by CHWs. The investigators will also test the cost-effectiveness of ASMA, and examine the barriers and facilitators of ASMA's widespread implementation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
359

participants targeted

Target at P75+ for not_applicable asthma

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable asthma

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 11, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 23, 2018

Completed
6 months until next milestone

Study Start

First participant enrolled

November 18, 2018

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 19, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 19, 2024

Completed
Last Updated

August 9, 2024

Status Verified

August 1, 2024

Enrollment Period

5.2 years

First QC Date

May 11, 2018

Last Update Submit

August 8, 2024

Conditions

Keywords

Asthma Self-Management for Adolescents (ASMA)Community Health Workers (CHW)

Outcome Measures

Primary Outcomes (2)

  • Number of night awakenings due to asthma symptoms

    Teens and caregivers report the frequency of night awakenings in the prior weeks.

    Up to 1 year

  • Number of days with asthma-related activity limitations

    Teens and caregivers report the frequency of limitations due to asthma in the prior weeks.

    Up to 1 year

Study Arms (2)

Asthma Self-Management for Adolescents

EXPERIMENTAL

Asthma Self-Management for Adolescents (ASMA) consists of three complementary components: (1) an 8- week intervention for students; (2) caregiver education; and (3) education for students' medical providers.

Behavioral: ASMA

Attention Control

NO INTERVENTION

In 3 group sessions and 5 one-on-one sessions, held at school during the school day, students will receive information about asthma and other health topics relevant to adolescents (e.g., nutrition, safety). They will learn to monitor their health by using diaries to record behaviors, such as what they eat, and/or their sleep patterns. Students will be referred to their medical providers for asthma and other health concerns; if they do not have a provider, they are given referrals in their community.

Interventions

ASMABEHAVIORAL

ASMA, grounded in social cognitive theory and utilizing motivational interviewing techniques, guides adolescents in their transition to being consumers and teaching them to navigate the health system, including overcoming challenges to health care access. Briefly, it consists of three complementary components: (1) an 8- week intervention for students; (2) caregiver education; and (3) education for students' medical providers.

Asthma Self-Management for Adolescents

Eligibility Criteria

Age13 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Adolescents who are at least 13.0 at the time of consent
  • Teenager reports having a prior asthma diagnosis, and in the last 12 months has: (a) used prescribed asthma medication and (b) uncontrolled asthma, defined as: (i) symptoms 3+ days a week; (ii) night awakenings 3+ nights per month; (iii) 2+ ED visits; or (iv) 1+ hospitalization for asthma; and
  • Adolescents are English proficient

You may not qualify if:

  • Co-morbid diseases that affect lung functioning.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina (MUSC)

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Conditions

Asthma

Interventions

MUSK protein, human

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Jean-Marie Bruzzese, PhD

    Columbia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The research assistants who will interview study participants will be blind to study condition.
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Applied Developmental Psychology (in Nursing)

Study Record Dates

First Submitted

May 11, 2018

First Posted

May 23, 2018

Study Start

November 18, 2018

Primary Completion

January 19, 2024

Study Completion

January 19, 2024

Last Updated

August 9, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

All data shared between sites will be de-identified by HIPAA standards using the "safe-harbor" method (i.e., all 18 identifiers will be stripped) prior to being scanned and stored on a password-protected webserver.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Available for up to 7 years from the end of the study.
Access Criteria
Deidentified data.

Locations